Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Dementia and Movement Disorder Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Dementia and Movement Disorder Treatmentmarket, defines the market attractiveness level of Dementia and Movement Disorder Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Dementia and Movement Disorder Treatment industry, describes the types of Dementia and Movement Disorder Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Dementia and Movement Disorder Treatment market and the development prospects and opportunities of Dementia and Movement Disorder Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Dementia and Movement Disorder Treatment market in Chapter 13.
By Player:
Allergan
Teva Pharmaceutical Industries
F Hoffmann-La Roche
Amgen
Novartis
Eisai
Pfizer
Eli Lilly
UCB
H Lundbeck
By Type:
MAO inhibitors (monoamine oxidase)
AChE inhibitors (acetylcholinesterase)
Glutamate inhibitors
By End-User:
Branded drugs
Generic drugs
Off-label drugs
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Dementia and Movement Disorder Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Dementia and Movement Disorder Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Dementia and Movement Disorder Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Dementia and Movement Disorder Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Dementia and Movement Disorder Treatment Market Analysis and Outlook to 2022
-
7.1 Global Dementia and Movement Disorder Treatment Consumption (2017-2022)
-
7.2 United States Dementia and Movement Disorder Treatment Consumption (2017-2022)
-
7.3 Europe Dementia and Movement Disorder Treatment Consumption (2017-2022)
-
7.4 China Dementia and Movement Disorder Treatment Consumption (2017-2022)
-
7.5 Japan Dementia and Movement Disorder Treatment Consumption (2017-2022)
-
7.6 India Dementia and Movement Disorder Treatment Consumption (2017-2022)
-
7.7 South Korea Dementia and Movement Disorder Treatment Consumption (2017-2022)
8 Region and Country-wise Dementia and Movement Disorder Treatment Market Analysis and Outlook to 2028
-
8.1 Global Dementia and Movement Disorder Treatment Consumption Forecast (2022-2028)
-
8.2 United States Dementia and Movement Disorder Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Dementia and Movement Disorder Treatment Consumption Forecast (2022-2028)
-
8.4 China Dementia and Movement Disorder Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Dementia and Movement Disorder Treatment Consumption Forecast (2022-2028)
-
8.6 India Dementia and Movement Disorder Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Dementia and Movement Disorder Treatment Consumption Forecast (2022-2028)
9 Global Dementia and Movement Disorder Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Dementia and Movement Disorder Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global MAO inhibitors (monoamine oxidase) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global AChE inhibitors (acetylcholinesterase) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Glutamate inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global Dementia and Movement Disorder Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Branded drugs Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Generic drugs Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Off-label drugs Consumption and Growth Rate (2017-2022)
10 Global Dementia and Movement Disorder Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Dementia and Movement Disorder Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global MAO inhibitors (monoamine oxidase) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global AChE inhibitors (acetylcholinesterase) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Glutamate inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Dementia and Movement Disorder Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Branded drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Generic drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Off-label drugs Consumption Forecast and Growth Rate (2022-2028)
11 Global Dementia and Movement Disorder Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Dementia and Movement Disorder Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Dementia and Movement Disorder Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Dementia and Movement Disorder Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Dementia and Movement Disorder Treatment Market Competitive Analysis
-
14.1 Allergan
-
14.1.1 Allergan Company Details
-
14.1.2 Allergan Dementia and Movement Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Allergan Dementia and Movement Disorder Treatment Product and Service
-
14.2 Teva Pharmaceutical Industries
-
14.2.1 Teva Pharmaceutical Industries Company Details
-
14.2.2 Teva Pharmaceutical Industries Dementia and Movement Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Teva Pharmaceutical Industries Dementia and Movement Disorder Treatment Product and Service
-
14.3 F Hoffmann-La Roche
-
14.3.1 F Hoffmann-La Roche Company Details
-
14.3.2 F Hoffmann-La Roche Dementia and Movement Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 F Hoffmann-La Roche Dementia and Movement Disorder Treatment Product and Service
-
14.4 Amgen
-
14.4.1 Amgen Company Details
-
14.4.2 Amgen Dementia and Movement Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Amgen Dementia and Movement Disorder Treatment Product and Service
-
14.5 Novartis
-
14.5.1 Novartis Company Details
-
14.5.2 Novartis Dementia and Movement Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis Dementia and Movement Disorder Treatment Product and Service
-
14.6 Eisai
-
14.6.1 Eisai Company Details
-
14.6.2 Eisai Dementia and Movement Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Eisai Dementia and Movement Disorder Treatment Product and Service
-
14.7 Pfizer
-
14.7.1 Pfizer Company Details
-
14.7.2 Pfizer Dementia and Movement Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Dementia and Movement Disorder Treatment Product and Service
-
14.8 Eli Lilly
-
14.8.1 Eli Lilly Company Details
-
14.8.2 Eli Lilly Dementia and Movement Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Eli Lilly Dementia and Movement Disorder Treatment Product and Service
-
14.9 UCB
-
14.9.1 UCB Company Details
-
14.9.2 UCB Dementia and Movement Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 UCB Dementia and Movement Disorder Treatment Product and Service
-
14.10 H Lundbeck
-
14.10.1 H Lundbeck Company Details
-
14.10.2 H Lundbeck Dementia and Movement Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 H Lundbeck Dementia and Movement Disorder Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Dementia and Movement Disorder Treatment
-
Figure Dementia and Movement Disorder Treatment Picture
-
Table Global Dementia and Movement Disorder Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Dementia and Movement Disorder Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Dementia and Movement Disorder Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Dementia and Movement Disorder Treatment Consumption by Country (2017-2022)
-
Figure United States Dementia and Movement Disorder Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Dementia and Movement Disorder Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Dementia and Movement Disorder Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Dementia and Movement Disorder Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Dementia and Movement Disorder Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Dementia and Movement Disorder Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Dementia and Movement Disorder Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Dementia and Movement Disorder Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Dementia and Movement Disorder Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Dementia and Movement Disorder Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Dementia and Movement Disorder Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Dementia and Movement Disorder Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Dementia and Movement Disorder Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global MAO inhibitors (monoamine oxidase) Consumption and Growth Rate (2017-2022)
-
Figure Global AChE inhibitors (acetylcholinesterase) Consumption and Growth Rate (2017-2022)
-
Figure Global Glutamate inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Branded drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Generic drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Off-label drugs Consumption and Growth Rate (2017-2022)
-
Figure Global MAO inhibitors (monoamine oxidase) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AChE inhibitors (acetylcholinesterase) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glutamate inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Branded drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Generic drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Off-label drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Dementia and Movement Disorder Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Dementia and Movement Disorder Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Dementia and Movement Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Dementia and Movement Disorder Treatment Product and Service
-
Table Teva Pharmaceutical Industries (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Dementia and Movement Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Dementia and Movement Disorder Treatment Product and Service
-
Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Dementia and Movement Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Dementia and Movement Disorder Treatment Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Dementia and Movement Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Dementia and Movement Disorder Treatment Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Dementia and Movement Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Dementia and Movement Disorder Treatment Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Dementia and Movement Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Dementia and Movement Disorder Treatment Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Dementia and Movement Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Dementia and Movement Disorder Treatment Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Dementia and Movement Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Dementia and Movement Disorder Treatment Product and Service
-
Table UCB (Foundation Year, Company Profile and etc.)
-
Table UCB Dementia and Movement Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB Dementia and Movement Disorder Treatment Product and Service
-
Table H Lundbeck (Foundation Year, Company Profile and etc.)
-
Table H Lundbeck Dementia and Movement Disorder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table H Lundbeck Dementia and Movement Disorder Treatment Product and Service
-
